Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Notice of AGM

14th May 2014 10:00

RNS Number : 0706H
Source BioScience PLC
14 May 2014
 



 

14 May 2014

 

Source BioScience plc

('Source BioScience' or 'the Company')

 

 

Notice of Annual General Meeting and posting of

Annual Report and Accounts

 

Source BioScience (LSE: SBS) announces that its 2014 Annual General Meeting will be held at the Company's registered office, 1 Orchard Place, Nottingham Business Park, Nottingham NG8 6PX at 10.30 am on 12 June 2014. Formal notice of this meeting is available on the website and has been posted to shareholders together with a copy of the 31 December 2013 Annual Report and Accounts, a copy of which can be downloaded from the Source BioScience website - www.sourcebioscience.com. 

 

 

-- ENDS --

 

For further information, please contact:

Source BioScience plcNick AshChief Executive OfficerTel: +44 (0)115 973 9010www.sourcebioscience.com

For investor and media enquiries:

N+1 Singer (Financial Advisor, Sponsor and Broker)Aubrey Powell/Joe StroudTel: +44 (0)207 496 3000www.nplus1singer.com

Instinctif Limited (PR Agency to Source BioScience)Melanie Toyne-Sewell/Jen LewisTel: +44 (0)207 457 2020Email: [email protected]

 

About Source BioScience:

Source BioScience (LSE: SBS) is an international laboratory services and products business serving the healthcare and life science research markets. The Healthcare operations provide screening and reference laboratory diagnostic testing for cancer and other diseases in addition to complementary products for serology, diagnostics and sample storage. The LifeSciences division provides gene-based laboratory research support from conceptualisation to implementation, calling upon a wide range of innovative technology platforms and an online catalogue of biomolecular tools including cDNA clones and antibodies. The Stability and Bio Storage division provides support for drug discovery, from biomarker discovery and clinical trial services through to stability storage and sample archiving under environmentally controlled conditions. A superior quality management system, including GLP, GCP, GMP and CPA accreditations, make the services very attractive for applications in regulatory studies or in a clinical and diagnostic setting. Source BioScience has its headquarters in Nottingham, UK. For more information, see www.sourcebioscience.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NOAAIMRTMBABMBI

Related Shares:

SBS.L
FTSE 100 Latest
Value8,275.66
Change0.00